3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 2/3
2
Phase 1/2
2
Phase NA
1
Phase 3
1
Phase 1
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
2
Myelodysplastic Syndromes
1
Interventions
venetoclax
12
Cytarabine
12
Azacitidine
10
Decitabine
8
Daunorubicin
7
Cyclophosphamide
7
Busulfan
6
fludarabine phosphate
5
Idarubicin
5
Gemtuzumab
5
Thiotepa
3
Stem Cell Transplantation
3
Filgrastim
3
Cyclosporine
3
vosaroxin
2
fludarabine
2
Whole-Body Irradiation
2
Tretinoin
2
Sorafenib
2
Radiotherapy
2
Methylprednisolone
2
Methotrexate
2
Melphalan
2
Injections
2
Etoposide
2
Cladribine
2
CPX-351
2
Antilymphocyte Serum
2
Abatacept
2
vedolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Leukemia, Myeloid, Acute
×
vosaroxin
×
Clear all
NCT02416388
2024-08-07
BIG-1
University Hospital, Angers
Phase 2/3
Recruiting
3,100 enrolled
NCT02272478
2020-01-23
AML18
Cardiff University
Phase 2/3
Unknown
1,600 enrolled